Browne L Daniel

Number of records: 44
SEC FilingCompany/StockTrade DateTransactionSharesAvg. PriceTotal% HoldingsGain/Loss
02-Jul-19 9:15 PM
View: 
Revance Therapeutics, Inc. (RVNC) 28-Jun-19Acquisition (other) 1,000$11.02$11,024.50< 1%
151.6K to 152.6K
(< 1%)
19-Mar-19 9:01 PM
View: 
Revance Therapeutics, Inc. (RVNC) 18-Mar-19Market Sale (Planned) 11,613$15.51$180,068.00(7%)
163.22K to 151.6K
(3%)
19-Mar-19 9:01 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Mar-19Payment of Exercise 6,137$15.45$94,816.60(4%)
169.35K to 163.22K
(4%)
20-Feb-19 9:31 PM
View: 
Revance Therapeutics, Inc. (RVNC) 19-Feb-19Market Sale (Planned) 5,446$17.68$96,285.30(3%)
174.8K to 169.35K
< 1%
20-Feb-19 9:31 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Feb-19Payment of Exercise 3,154$17.69$55,794.30(2%)
177.95K to 174.8K
< 1%
25-Jan-19 9:02 PM
View: 
Revance Therapeutics, Inc. (RVNC) 24-Jan-19Grant 35,000----24%
142.95K to 177.95K
03-Jul-18 8:17 PM
View: 
Revance Therapeutics, Inc. (RVNC) 29-Jun-18Acquisition (other) 668$23.33$15,586.10< 1%
142.28K to 142.95K
16-Mar-18 8:03 PM
View: 
Revance Therapeutics, Inc. (RVNC) 16-Mar-18Option Exercise 20,000$2.55$51,000.0016%
127.74K to 147.74K
16-Mar-18 8:03 PM
View: 
Revance Therapeutics, Inc. (RVNC) 16-Mar-18Market Option Sale (Planned) 5,452$31.43$171,348.00(4%)
147.74K to 142.28K
44%
16-Mar-18 8:03 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Mar-18Payment of Exercise 2,881$31.65$91,183.60(2%)
131.62K to 128.74K
44%
16-Mar-18 8:03 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Mar-18Market Option Sale (Planned) 1,000$32.80$32,800.00(< 1%)
128.74K to 127.74K
46%
09-Mar-18 8:36 PM
View: 
Revance Therapeutics, Inc. (RVNC) 07-Mar-18Market Sale (Planned) 27,283$31.43$857,505.00(17%)
158.9K to 131.62K
44%
16-Feb-18 7:42 PM
View: 
Revance Therapeutics, Inc. (RVNC) 15-Feb-18Payment of Exercise 3,074$31.75$97,599.50(2%)
161.97K to 158.9K
44%
09-Feb-18 9:21 PM
View: 
Revance Therapeutics, Inc. (RVNC) 08-Feb-18Grant 28,250----21%
133.72K to 161.97K
03-Jan-18 8:13 PM
View: 
Revance Therapeutics, Inc. (RVNC) 29-Dec-17Acquisition (other) 127$22.99$2,920.05< 1%
133.6K to 133.72K
24-Nov-17 4:06 PM
View: 
Revance Therapeutics, Inc. (RVNC) 22-Nov-17Market Sale (Planned) 7,600$24.94$189,570.00(5%)
141.2K to 133.6K
29%
20-Oct-17 8:10 PM
View: 
Revance Therapeutics, Inc. (RVNC) 18-Oct-17Market Sale (Planned) 7,662$26.16$200,405.00(5%)
148.86K to 141.2K
32%
22-Sep-17 8:08 PM
View: 
Revance Therapeutics, Inc. (RVNC) 20-Sep-17Market Sale (Planned) 7,600$23.58$179,185.00(5%)
156.46K to 148.86K
25%
25-Aug-17 7:41 PM
View: 
Revance Therapeutics, Inc. (RVNC) 23-Aug-17Option Exercise 331$2.55$844.05< 1%
178.93K to 179.26K
25-Aug-17 7:41 PM
View: 
Revance Therapeutics, Inc. (RVNC) 23-Aug-17Market Option Sale (Planned) 331$22.76$7,535.05(< 1%)
179.26K to 178.93K
22%
25-Aug-17 7:41 PM
View: 
Revance Therapeutics, Inc. (RVNC) 23-Aug-17Market Sale (Planned) 22,469$22.76$511,496.00(13%)
178.93K to 156.46K
22%
05-Jul-17 9:29 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Jun-17Acquisition (other) 1,000$18.32$18,317.50< 1%
177.93K to 178.93K
14-Jun-17 8:11 PM
View: 
Revance Therapeutics, Inc. (RVNC) 12-Jun-17Option Exercise 8,300$2.55$21,165.005%
169.63K to 177.93K
31-May-17 9:38 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-May-17Option Exercise 5,000$2.55$12,750.003%
164.63K to 169.63K
24-May-17 9:13 PM
View: 
Revance Therapeutics, Inc. (RVNC) 24-May-17Market Sale (Planned) 19,713$20.35$401,091.00(11%)
184.34K to 164.63K
13%
24-May-17 9:13 PM
View: 
Revance Therapeutics, Inc. (RVNC) 22-May-17Market Sale (Planned) 12,287$20.20$248,159.00(6%)
196.63K to 184.34K
12%
17-Mar-17 7:23 PM
View: 
Revance Therapeutics, Inc. (RVNC) 16-Mar-17Payment of Exercise 3,171$19.20$60,885.40(2%)
199.8K to 196.63K
8%
24-Feb-17 9:04 PM
View: 
Revance Therapeutics, Inc. (RVNC) 22-Feb-17Market Sale (Planned) 11,037$20.57$227,050.00(5%)
210.84K to 199.8K
14%
30-Jan-17 9:28 PM
View: 
Revance Therapeutics, Inc. (RVNC) 26-Jan-17Grant 25,800----14%
185.04K to 210.84K
27-Jan-17 8:04 PM
View: 
Revance Therapeutics, Inc. (RVNC) 25-Jan-17Market Sale (Planned) 12,000$19.78$237,398.00(6%)
197.04K to 185.04K
11%
03-Jan-17 5:52 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Dec-16Acquisition (other) 1,000$11.58$11,577.00< 1%
196.04K to 197.04K
30-Dec-16 6:38 PM
View: 
Revance Therapeutics, Inc. (RVNC) 28-Dec-16Market Sale (Planned) 12,000$20.94$251,250.00(6%)
208.04K to 196.04K
15%
25-Nov-16 9:32 PM
View: 
Revance Therapeutics, Inc. (RVNC) 25-Nov-16Market Sale (Planned) 12,000$17.92$215,005.00(5%)
220.04K to 208.04K
11%
28-Oct-16 9:29 PM
View: 
Revance Therapeutics, Inc. (RVNC) 26-Oct-16Market Sale (Planned) 12,000$14.85$178,199.00(5%)
232.04K to 220.04K
(5%)
23-May-16 9:28 PM
View: 
Revance Therapeutics, Inc. (RVNC) 19-May-16Payment of Exercise 12,050$17.11$206,176.00(5%)
244.09K to 232.04K
9%
11-Feb-16 8:15 PM
View: 
Revance Therapeutics, Inc. (RVNC) 09-Feb-16Grant 25,000----11%
219.09K to 244.09K
04-Jan-16 9:10 PM
View: 
Revance Therapeutics, Inc. (RVNC) 31-Dec-15Acquisition (other) 262$27.00$7,074.00< 1%
218.82K to 219.09K
04-Jan-16 9:10 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Dec-15Option Exercise 12,045$2.55$30,714.806%
206.78K to 218.82K
02-Jul-15 8:35 PM
View: 
Revance Therapeutics, Inc. (RVNC) 30-Jun-15Acquisition (other) 1,000$14.16$14,160.00< 1%
205.78K to 206.78K
21-May-15 6:46 PM
View: 
Revance Therapeutics, Inc. (RVNC) 19-May-15Payment of Exercise 12,025$25.94$311,928.00(6%)
217.8K to 205.78K
40%
30-Jan-15 7:09 PM
View: 
Revance Therapeutics, Inc. (RVNC) 28-Jan-15Grant 43,500----25%
174.03K to 217.53K
01-Dec-14 9:26 PM
View: 
Revance Therapeutics, Inc. (RVNC) 28-Nov-14Market Purchase 6,000$16.67$100,019.004%
168.03K to 174.03K
(6%)
21-May-14 9:30 PM
View: 
Revance Therapeutics, Inc. (RVNC) 19-May-14Grant 96,000$32.22$3,093,120.00135%
71.03K to 167.03K
(51%)
11-Feb-14 1:37 PM
View: 
Revance Therapeutics, Inc. (RVNC) 11-Feb-14Conversion 17,702----33%
53.33K to 71.03K